Cargando…

Patients With Schizophrenia-Spectrum Disorders as Vulnerable Populations in an Age of Misinformation: A Case Report of Ivermectin-Related Liver Failure

Detalles Bibliográficos
Autores principales:	Fioravante, Nicholas, Kozak, Zofia, Glovinsky, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. 2022
Materias:	Letter to the Editor: Brief Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747241/ https://www.ncbi.nlm.nih.gov/pubmed/36522037 http://dx.doi.org/10.1016/j.jaclp.2022.08.004

Ejemplares similares

Misinformation, Trust, and Use of Ivermectin and Hydroxychloroquine for COVID-19
por: Perlis, Roy H., et al.
Publicado: (2023)

Ivermectin and COVID-19
por: Wiwanitkit, Viroj
Publicado: (2021)

Misconceptions and misinformation about bats and viruses
por: Puechmaille, Sebastien J., et al.
Publicado: (2021)

Lessons Learned from Ivermectin
por: Watari, Takashi, et al.
Publicado: (2023)

Trauma and dissociation among inpatients diagnosed with schizophrenia spectrum disorders in Taiwan
por: Wu, Zi Yi, et al.
Publicado: (2022)

Reply to “Misconceptions and misinformation about bats and viruses”
por: Bonilla-Aldana, D. Katterine, et al.
Publicado: (2021)

The Use of Ivermectin in the Treatment of COVID-19
por: Shukla, Ajay Kumar, et al.
Publicado: (2023)

Ivermectin: potential candidate for the treatment of Covid 19
por: Gupta, Dhyuti, et al.
Publicado: (2020)

Ivermectin: Panacea or true promise for COVID-19
por: Heimfarth, Luana, et al.
Publicado: (2020)

“Social Media Misinformation”—An Epidemic within the COVID-19 Pandemic
por: Ahmed Siddiqui, Mohammed Yaseen, et al.
Publicado: (2020)

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
por: Shukla, Dr. Ajay Kumar, et al.
Publicado: (2021)

Battling pseudoscience in the era of medical misinformation – rising role of health advocacy
por: Kumar, Dinesh
Publicado: (2019)

COVID-19 and misinformation: how an infodemic fuelled the prominence of vitamin D
por: Henrina, Joshua, et al.
Publicado: (2020)

Some Epidemiologic Studies of Low-Dose-Radiation Cancer Risks Are Misinforming
por: Scott, Bobby R.
Publicado: (2021)

Opportunities to investigate the effects of ivermectin mass drug administration on scabies
por: Engelman, Daniel, et al.
Publicado: (2013)

Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors
por: Mandelli, Laura, et al.
Publicado: (2016)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Cervical cancer screening and psychosis: a longitudinal retrospective study comparing women with schizophrenia spectrum disorders and the general population
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2022)

Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs
por: Millington, David S., et al.
Publicado: (2017)

Misinformation in Wake of the COVID-19 Outbreak: Fueling Shortage and Misuse of Lifesaving Drugs in Pakistan
por: Hashmi, Furqan Khurshid, et al.
Publicado: (2020)

Persisting on Readability Could Provoke the Risk of Misinformation: A COVID-19 Pandemic Concern
por: Hosseini, Mohammad-Salar, et al.
Publicado: (2021)

A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?
por: Shafiee, Arman, et al.
Publicado: (2023)

Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19()
por: Portmann-Baracco, Arianna, et al.
Publicado: (2020)

Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?
por: O’Higgins, Marcelo G., et al.
Publicado: (2021)

Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
por: Chu, Ryan Sai-Ting, et al.
Publicado: (2021)

Misinformation induced anxieties and fear affecting vaccination programs: Challenge for COVID-19 vaccination program
por: Ganie, Aasim Ur R., et al.
Publicado: (2022)

Stress reduces the incorporation of misinformation into an established memory
por: Schmidt, Pia-Isabell, et al.
Publicado: (2014)

A five-day course of ivermectin may reduce the duration of COVID-19 illness
por: Ahmed, Sabeena, et al.
Publicado: (2021)

Misinformation in the COVID-19 era
por: Toth, Gabor, et al.
Publicado: (2020)

A cross-lingual analysis on the spread of misinformation using the case of Ivermectin as a treatment for Covid-19
por: Lai, Cameron, et al.
Publicado: (2023)

Autism spectrum disorder: A mitochondrial disorder
por: FINSTERER, Josef
Publicado: (2021)

A nation-wide twin study of social cognition in schizophrenia spectrum disorders
por: Lemvigh, Cecilie K., et al.
Publicado: (2022)

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
por: Sommer, Iris E, et al.
Publicado: (2022)

Considerations on the article «antiviral and anti-inflammatory properties of ivermectin and its potential use in COVID-19»()
por: Hernández-Vásquez, Akram, et al.
Publicado: (2020)

Ia afferent fibers in peripheral nerve disorders: Evidence for divergent vulnerability
por: García, Antonio, et al.
Publicado: (2021)

Breaking (Fake) News: No Personal Relevance Effect on Misinformation Vulnerability
por: Ceccarini, Francesco, et al.
Publicado: (2023)

Electroencephalography in patients with autism spectrum disorder
por: Asadi-Pooya, Ali A
Publicado: (2021)

The tsunami of misinformation on COVID-19 challenged the health information literacy of the general public and the readability of educational material: a commentary
por: Mokhtari, H., et al.
Publicado: (2020)

Perioral Dermatitis Successfully Treated with Topical Ivermectin
por: Charnowski, Sara, et al.
Publicado: (2019)

Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders
por: Melby, Katrine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_peiu872ovqif9dmpjlbgsa5f26